Ligand validation:8OY9

FDA: DIHYDROFLAVINE-ADENINE DINUCLEOTIDE

FDA is a Ligand Of Interest in 8OY9 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
8OY9_FDA_A_502	69%	60%	0.145	0.959	0.58	0.96	-	5	5	0	100%	1
8OY9_FDA_B_501	56%	63%	0.166	0.938	0.64	0.77	-	2	1	0	100%	1
8OET_FDA_A_502	83%	63%	0.133	0.991	0.65	0.76	-	2	1	0	100%	1
8OY4_FDA_A_502	72%	61%	0.135	0.959	0.64	0.84	-	3	7	0	100%	1
8OY8_FDA_A_502	70%	61%	0.142	0.959	0.63	0.85	-	4	2	0	100%	1
8OYA_FDA_A_502	66%	63%	0.153	0.959	0.62	0.81	-	2	1	0	100%	1
8OY3_FDA_A_502	66%	62%	0.158	0.963	0.63	0.82	-	3	1	0	100%	1
4OPD_FDA_B_501	100%	67%	0.02	0.995	0.55	0.71	-	1	4	0	100%	1
3UKF_FDA_B_600	100%	10%	0.026	0.995	2.22	2.05	19	19	2	0	100%	1
3TSH_FDA_A_601	100%	38%	0.04	0.992	1.03	1.38	3	6	3	0	100%	1
4MOR_FDA_B_801	100%	15%	0.037	0.989	1.83	1.96	12	19	1	0	100%	1
4OPC_FDA_A_501	100%	64%	0.038	0.986	0.6	0.76	-	2	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.